Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.88M Sell
20,145
-1,264
-6% -$342K 0.11% 195
2025
Q4
$6.34M Buy
21,409
+6,254
+41% +$1.87M 0.14% 157
2025
Q3
$4.28M Sell
15,155
-1,763
-10% -$461K 0.14% 160
2025
Q2
$4.99M Buy
16,918
+13,935
+467% +$3.59M 0.16% 150
2025
Q1
$742K Sell
2,983
-5,839
-66% -$1.43M 0.06% 251
2024
Q4
$1.94M Buy
8,822
+7,589
+615% +$1.69M 0.12% 158
2024
Q3
$273K Sell
1,233
-58
-4% -$11.4K 0.05% 150
2024
Q2
$223K Buy
+1,291
New +$224K 0.04% 140

Other funds holding IBM

Callan Family Office's IBM Position: Q1 2026 in Review

Callan Family Office reduced its IBM (IBM) stake by 5.9% in Q1 2026, selling an estimated $342K and leaving 20,145 shares worth $4.88M. The position accounts for 0.11% of the portfolio, ranked #195.

Callan Family Office first reported a position in IBM in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.34M in Q4 2025. 3,463 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Callan Family Office held 20,145 shares of IBM worth $4.88M as of Q1 2026.
  • Callan Family Office sold 1,264 IBM shares in Q1 2026, an estimated $342K.
  • IBM made up 0.11% of Callan Family Office's portfolio in Q1 2026, its #195 holding.
  • Callan Family Office first reported a position in IBM in Q2 2024 and has held it in 8 quarters since.
  • Callan Family Office's IBM position peaked at $6.34M in Q4 2025.
  • 3,463 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.